SMS PHARMACEUTICALS
|
SMS PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity - Authorised | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity - Issued | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity Paid Up | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹29 Cr | - | - | - | - |
Total Reserves | ₹499 Cr | ₹452 Cr | ₹462 Cr | ₹402 Cr | ₹340 Cr |
Securities Premium | ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹70 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹325 Cr | ₹288 Cr | ₹297 Cr | ₹248 Cr | ₹195 Cr |
General Reserves | ₹103 Cr | ₹93 Cr | ₹93 Cr | ₹83 Cr | ₹73 Cr |
Other Reserves | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr |
Reserve excluding Revaluation Reserve | ₹499 Cr | ₹452 Cr | ₹462 Cr | ₹402 Cr | ₹340 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹536 Cr | ₹461 Cr | ₹470 Cr | ₹411 Cr | ₹348 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹121 Cr | ₹120 Cr | ₹148 Cr | ₹146 Cr | ₹67 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹74 Cr | ₹67 Cr | ₹81 Cr | ₹81 Cr | ₹56 Cr |
Term Loans - Institutions | ₹75 Cr | ₹68 Cr | ₹81 Cr | ₹74 Cr | ₹34 Cr |
Other Secured | ₹-27 Cr | ₹-15 Cr | ₹-14 Cr | ₹-9.15 Cr | ₹-23 Cr |
Unsecured Loans | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr |
Deferred Tax Assets / Liabilities | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr | ₹40 Cr |
Deferred Tax Assets | ₹2.56 Cr | ₹2.87 Cr | ₹3.38 Cr | ₹5.37 Cr | ₹14 Cr |
Deferred Tax Liability | ₹45 Cr | ₹44 Cr | ₹43 Cr | ₹59 Cr | ₹53 Cr |
Other Long Term Liabilities | - | ₹0.61 Cr | ₹2.11 Cr | ₹3.16 Cr | ₹4.78 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.16 Cr | ₹1.41 Cr | ₹1.57 Cr | ₹1.84 Cr | ₹1.73 Cr |
Total Non-Current Liabilities | ₹166 Cr | ₹164 Cr | ₹193 Cr | ₹206 Cr | ₹114 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹151 Cr | ₹107 Cr | ₹73 Cr | ₹65 Cr | ₹44 Cr |
Sundry Creditors | ₹151 Cr | ₹107 Cr | ₹73 Cr | ₹65 Cr | ₹44 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹65 Cr | ₹53 Cr | ₹55 Cr | ₹58 Cr | ₹39 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.98 Cr | ₹1.15 Cr | ₹1.25 Cr | ₹4.66 Cr | ₹9.32 Cr |
Interest Accrued But Not Due | ₹0.58 Cr | - | - | - | ₹0.71 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹63 Cr | ₹52 Cr | ₹53 Cr | ₹54 Cr | ₹29 Cr |
Short Term Borrowings | ₹114 Cr | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr |
Secured ST Loans repayable on Demands | ₹114 Cr | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr |
Working Capital Loans- Sec | ₹114 Cr | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-114 Cr | ₹-94 Cr | ₹-68 Cr | ₹-71 Cr | ₹-61 Cr |
Short Term Provisions | ₹16 Cr | ₹1.10 Cr | ₹16 Cr | ₹17 Cr | ₹9.72 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹15 Cr | ₹0.06 Cr | ₹15 Cr | ₹16 Cr | ₹9.00 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.03 Cr | ₹1.04 Cr | ₹1.02 Cr | ₹0.82 Cr | ₹0.72 Cr |
Total Current Liabilities | ₹347 Cr | ₹255 Cr | ₹211 Cr | ₹211 Cr | ₹154 Cr |
Total Liabilities | ₹1,049 Cr | ₹880 Cr | ₹875 Cr | ₹828 Cr | ₹617 Cr |
ASSETS | |||||
Gross Block | ₹632 Cr | ₹576 Cr | ₹570 Cr | ₹559 Cr | ₹361 Cr |
Less: Accumulated Depreciation | ₹195 Cr | ₹164 Cr | ₹132 Cr | ₹101 Cr | ₹80 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹437 Cr | ₹412 Cr | ₹438 Cr | ₹457 Cr | ₹280 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹30 Cr | ₹33 Cr | ₹11 Cr | ₹6.74 Cr | ₹42 Cr |
Non Current Investments | ₹11 Cr | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr |
Long Term Investment | ₹11 Cr | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹11 Cr | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr |
Long Term Loans & Advances | ₹19 Cr | ₹11 Cr | ₹9.32 Cr | ₹9.10 Cr | ₹38 Cr |
Other Non Current Assets | ₹2.69 Cr | ₹2.54 Cr | ₹2.61 Cr | ₹2.38 Cr | ₹2.25 Cr |
Total Non-Current Assets | ₹500 Cr | ₹469 Cr | ₹482 Cr | ₹503 Cr | ₹389 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹234 Cr | ₹223 Cr | ₹251 Cr | ₹138 Cr | ₹129 Cr |
Raw Materials | ₹88 Cr | ₹79 Cr | ₹70 Cr | ₹70 Cr | ₹34 Cr |
Work-in Progress | ₹90 Cr | ₹106 Cr | ₹119 Cr | ₹23 Cr | ₹44 Cr |
Finished Goods | ₹48 Cr | ₹32 Cr | ₹59 Cr | ₹25 Cr | ₹48 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹7.39 Cr | ₹6.84 Cr | ₹3.23 Cr | ₹19 Cr | ₹3.37 Cr |
Sundry Debtors | ₹236 Cr | ₹148 Cr | ₹49 Cr | ₹106 Cr | ₹49 Cr |
Debtors more than Six months | ₹0.36 Cr | ₹1.69 Cr | ₹0.85 Cr | ₹2.10 Cr | - |
Debtors Others | ₹236 Cr | ₹147 Cr | ₹48 Cr | ₹104 Cr | ₹49 Cr |
Cash and Bank | ₹36 Cr | ₹7.47 Cr | ₹47 Cr | ₹41 Cr | ₹9.65 Cr |
Cash in hand | ₹0.08 Cr | ₹0.08 Cr | ₹0.07 Cr | ₹0.09 Cr | ₹0.12 Cr |
Balances at Bank | ₹36 Cr | ₹7.39 Cr | ₹47 Cr | ₹40 Cr | ₹9.54 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹6.77 Cr | ₹6.00 Cr | ₹6.39 Cr | ₹19 Cr | ₹21 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.38 Cr | ₹0.38 Cr | ₹0.02 Cr | ₹0.11 Cr | ₹0.14 Cr |
Prepaid Expenses | ₹5.25 Cr | ₹4.93 Cr | ₹3.31 Cr | ₹2.22 Cr | ₹1.87 Cr |
Other current_assets | ₹1.14 Cr | ₹0.69 Cr | ₹3.07 Cr | ₹17 Cr | ₹19 Cr |
Short Term Loans and Advances | ₹36 Cr | ₹25 Cr | ₹39 Cr | ₹22 Cr | ₹19 Cr |
Advances recoverable in cash or in kind | ₹8.92 Cr | ₹3.52 Cr | ₹4.79 Cr | ₹3.18 Cr | ₹7.10 Cr |
Advance income tax and TDS | ₹17 Cr | ₹5.82 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹10 Cr | ₹16 Cr | ₹15 Cr | - | - |
Total Current Assets | ₹549 Cr | ₹411 Cr | ₹392 Cr | ₹325 Cr | ₹228 Cr |
Net Current Assets (Including Current Investments) | ₹202 Cr | ₹156 Cr | ₹181 Cr | ₹114 Cr | ₹74 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,049 Cr | ₹880 Cr | ₹875 Cr | ₹828 Cr | ₹617 Cr |
Contingent Liabilities | ₹5.67 Cr | ₹2.75 Cr | ₹8.12 Cr | ₹7.01 Cr | ₹1.74 Cr |
Total Debt | ₹280 Cr | ₹253 Cr | ₹260 Cr | ₹251 Cr | ₹152 Cr |
Book Value | 59.98 | 54.40 | 55.56 | 48.50 | 41.14 |
Adjusted Book Value | 59.98 | 54.40 | 55.56 | 48.50 | 41.14 |
Compare Balance Sheet of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,737.6 Cr | 2.1% | -16.9% | 53.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | 2.1% |
-16.9% |
53.2% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses